{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:27:04Z","timestamp":1787009224351,"version":"build-2736575974"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>Invasive fungal infections pose a severe threat in unconventional immunocompromised hosts such as cirrhosis. Herein we review the impact of invasive aspergillosis (IA) on the prognosis of cirrhosis patients. An electronic search for full-text articles describing IA in cirrhosis was conducted and the disease outcomes and mortality (point-estimate and comparative risk) were pooled on random-effects meta-analysis. Of 4127 articles, 11 studies (9 with good\/fair and 2 with poor quality) were included. IA was associated with high disease severity and multi-organ failures in cirrhosis. The pooled-mortality of IA was 81.8% (95% CI: 64.3\u201391.8, I2\u00a0=\u00a059%, P &amp;lt; 0.01). Estimate's-heterogeneity (I2) was explored through sub-groups, meta-regression, and influential diagnostics. Mortality estimates were higher among subgroups of acute-on-chronic liver failure (ACLF, 86.4%) and intensive care unit (ICU)-admitted patients (84.0%). The odds of mortality related to IA were 8.9 times higher than controls and much higher in ACLF (OR: 22.5) and ICU-admitted patients (OR: 36.4). The odds of mortality in IA were 4.1, 12.9, and 48.6 times higher than bacterial, no-fungal infections, and no-infection controls. There was no asymmetry in mortality estimates or odds ratios and mortality in IA was high irrespective of country of origin, site of infection, proven or probable category, and quality of study. Thus, IA is associated with very high mortality in cirrhosis patients, especially in ACLF and ICU-admitted patients. Intensive research is needed for the rapid diagnosis and treatment of IA in cirrhosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lay summary<\/jats:title>\n                    <jats:p>We report a high mortality rate of 81.8% in patients with liver cirrhosis and invasive aspergillosis. Higher odds (8.9 times) of death, especially in patients with ACLF or ICU admission were seen. Mortality was not affected by the country of study, site of infection, proven or probable nature of infection category, and quality of study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/mmy\/myab044","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T15:10:20Z","timestamp":1627053020000},"page":"1092-1100","source":"Crossref","is-referenced-by-count":13,"title":["Invasive aspergillosis is a critical determinant of mortality in cirrhosis: a systematic review with meta-analysis"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4328-0914","authenticated-orcid":false,"given":"Nipun","family":"Verma","sequence":"first","affiliation":[{"name":"Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshi","family":"Syal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Government Medical College and Hospital, Chandigarh, 160032, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranita","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indian Council of Medical Research Center for Evidence-Based Child Health, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9653-1708","authenticated-orcid":false,"given":"Manvi","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indian Council of Medical Research Center for Evidence-Based Child Health, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indian Council of Medical Research Center for Evidence-Based Child Health, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,26]]},"reference":[{"key":"2021110223542591000_bib1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"key":"2021110223542591000_bib2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jhep.2015.05.032","article-title":"Fungal infections in patients with cirrhosis","volume":"63","author":"Alexopoulou","year":"2015","journal-title":"J Hepatol"},{"key":"2021110223542591000_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2021110223542591000_bib4","doi-asserted-by":"crossref","first-page":"e0186422","DOI":"10.1371\/journal.pone.0186422","article-title":"Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: an 11-year follow-up report from Taiwan","volume":"12","author":"Sun","year":"2017","journal-title":"PLoS One"},{"key":"2021110223542591000_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/liv.13981","article-title":"Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections","volume":"39","author":"Verma","year":"2019","journal-title":"Liver Int"},{"key":"2021110223542591000_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13613-019-0502-2","article-title":"Invasive pulmonary aspergillosis in cirrhotic patients: analysis of a 10-year clinical experience","volume":"9","author":"Levesque","year":"2019","journal-title":"Ann Intensive Care"},{"key":"2021110223542591000_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48183-4","article-title":"Prevalence and outcome of invasive pulmonary aspergillosis in critically ill patients with liver cirrhosis: an observational study","volume":"9","author":"Lahmer","year":"2019","journal-title":"Sci Rep"},{"key":"2021110223542591000_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/13693786.2010.535030","article-title":"Invasive aspergillosis in patients with liver disease","volume":"49","author":"Falcone","year":"2011","journal-title":"Med Mycol"},{"key":"2021110223542591000_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit Care"},{"key":"2021110223542591000_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/mmy\/myx029","article-title":"Epidemiology and clinical characteristics of invasive mould infections: a multicenter, retrospective analysis in five Asian countries","volume":"56","author":"Rotjanapan","year":"2018","journal-title":"Med Mycol"},{"key":"2021110223542591000_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/mmy\/myx011","article-title":"Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study","volume":"55","author":"Prattes","year":"2017","journal-title":"Med Mycol"},{"key":"2021110223542591000_bib12","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA Statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PloS Med"},{"key":"2021110223542591000_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J Hepatol"},{"key":"2021110223542591000_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the american association for the study of liver diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"2021110223542591000_bib15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021110223542591000_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110223542591000_bib17","author":"Wells"},{"key":"2021110223542591000_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jspi.2009.09.017","article-title":"How does the DerSimonian and Laird procedure for random effects meta-analysis compare with its more efficient but harder to compute counterparts?","volume":"140","author":"Jackson","year":"2010","journal-title":"J Stat Plan Inference"},{"key":"2021110223542591000_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2021110223542591000_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res Synth Methods"},{"key":"2021110223542591000_bib21","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41598-018-19320-2","article-title":"Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis","volume":"8","author":"Gao","year":"2018","journal-title":"Sci Rep"},{"key":"2021110223542591000_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11046-014-9740-x","article-title":"Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis","volume":"177","author":"Lahmer","year":"2014","journal-title":"Mycopathologia"},{"key":"2021110223542591000_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-6958-9-1","article-title":"Clinical findings in 19 cases of invasive pulmonary aspergillosis with liver cirrhosis","volume":"9","author":"Chen","year":"2014","journal-title":"Multidiscip Respir Med"},{"key":"2021110223542591000_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2013.12.014","article-title":"Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicion","volume":"23","author":"Hassan","year":"2014","journal-title":"Int J Infect Dis"},{"key":"2021110223542591000_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","article-title":"Invasive aspergillosis in patients with severe alcoholic hepatitis","volume":"60","author":"Gustot","year":"2014","journal-title":"J Hepatol"},{"key":"2021110223542591000_bib26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.7150\/ijms.6824","article-title":"Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study","volume":"10","author":"Chen","year":"2013","journal-title":"Int J Med Sci"},{"key":"2021110223542591000_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/myc.12044","article-title":"Invasive fungal infections secondary to acute-on-chronic liver failure: a retrospective study","volume":"56","author":"Lin","year":"2013","journal-title":"Mycoses"},{"key":"2021110223542591000_bib28","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1177\/030006051204000537","article-title":"Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure","volume":"40","author":"Wu","year":"2012","journal-title":"J Int Med Res"},{"key":"2021110223542591000_bib29","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1086\/591458","article-title":"Human platelets attenuate Aspergillus species via granule-dependent mechanisms","volume":"198","author":"Perkhofer","year":"2008","journal-title":"J Infect Dis"},{"key":"2021110223542591000_bib30","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myab044\/39769887\/myab044.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/11\/1092\/40811067\/myab044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/11\/1092\/40811067\/myab044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T19:54:46Z","timestamp":1635882886000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/59\/11\/1092\/6328485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,26]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,7,26]]},"published-print":{"date-parts":[[2021,11,3]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myab044","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11]]},"published":{"date-parts":[[2021,7,26]]}}}